A new experimental treatment for HIV could eliminate the need for daily medication and could keep the virus under control for up to two years.

A study conducted by British researchers has discovered a new experimental treatment for HIV that could revolutionize the way this condition is managed. Participants in the study, recruited from the UK and Denmark between 2021 and 2024, included 68 volunteers who received an antibody-based therapy capable of suppressing the HIV virus. The results show that approximately a quarter of the participants were able to remain without daily antiviral treatment for two years. Currently, most people diagnosed with HIV are required to take a pill every day, which, although not a cure, prevents the virus from multiplying in the body. This experimental therapy could significantly reduce costs for healthcare systems, which in the UK exceed £400 million annually for the medications of approximately 113,500 people with HIV.